Showing results (61-70 of 111) with videos related to
Sort By:
Pageof 12
Internal and Emergency Medicine|March 12, 2011
Etomidate use in severe sepsis and septic shock patients does not contribute to mortalityRobert Ehrman, Charles Wira, Afsaneh Lomax, et al.Journal of Geriatric Cardiology : JGC|October 25, 2019
Gender-specific associations between coronary heart disease and other chronic diseases: cross-sectional evaluation of national survey data from adult residents of GermanyMarie-Isabel K Murray, Kerstin Bode, Peter WhittakerThe Annals of Otology, Rhinology, and Laryngology|May 26, 2009
Lamina propria cellularity and collagen composition: an integrated assessment of structure in humansDany Muñoz-Pinto, Peter Whittaker, Mariah S HahnThe American Journal of Emergency Medicine|December 14, 2016
Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of strokeClaire Pearson, Karin Przyklenk, Valerie H Mika, et al.Journal of Clinical Epidemiology|July 27, 2026
Effect moderation and heterogeneity in meta-analysis: a meta-regression-based reinterpretation of surgical site infection risk factors after craniotomy and cranioplastyBei Wang, Mengyan Sun, Chunlai Ma, et al.Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 5, 2002
Delta opiates increase ischemic tolerance in isolated rabbit jejunumRobert J Tubbs, William A Porcaro, Won Jae Lee, et al.Scientific Reports|December 1, 2018
Publisher Correction: GLS-409, an Antagonist of Both P2Y1 and P2Y12, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet ActivationElena Smolensky Koganov, Alan D Michelson, Ivan B Yanachkov, et al.Scientific Reports|September 30, 2018
GLS-409, an Antagonist of Both P2Y1 and P2Y12, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet ActivationElena Smolensky Koganov, Alan D Michelson, Ivan B Yanachkov, et al.Cells|October 14, 2022
Does Disruption of Optic Atrophy-1 (OPA1) Contribute to Cell Death in HL-1 Cardiomyocytes Subjected to Lethal Ischemia-Reperfusion Injury?Andrew R Kulek, Vishnu V R Undyala, Anthony R Anzell, et al.The Annals of Pharmacotherapy|February 18, 2011
Authorship and characteristics of articles in pharmacy journals: changes over a 20-year intervalBryan Dotson, Kevin P McManus, Jing J Zhao, et al.Pageof 12